SCHEMBL32665477

SCHEMBL32665477

NC1CC2(CCN(c3ccc(OCc4ccccc4)cc3)CC2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 5/20 0.46
LTA4H P09960 1/20 0.46
KDM1A O60341 2/20 0.44
MAPT P10636 5/20 0.44
RAB9A P51151 3/20 0.44
MAOB P27338 2/20 0.44
GAA P10253 1/20 0.44
MAOA P21397 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
MMP13 P45452 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
CYP1A2 P05177 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665315 0.88 MAOB (0.49) PRMT5KDM1AMAOBSMN1; SMN2LMNA
SCHEMBL32665566 0.84 NPC1 (0.60) MAPTRAB9ASMN1; SMN2ALDH1A1HTT
SCHEMBL7891590 0.82 PRMT5 (0.55) PRMT5LTA4HKDM1AMAPTRAB9A
SCHEMBL20875967 0.81 MAOB (0.54) LTA4HKDM1AMAPTRAB9AMAOB
SCHEMBL737426 0.79 GRIN1 (0.47) LTA4HMAPTRAB9AGAALMNA
SCHEMBL737726 0.78 MAPT (0.48) PRMT5LTA4HMAPTRAB9AMAOB
SCHEMBL737235 0.77 MAPT (0.49) PRMT5LTA4HMAPTRAB9AMAOB
SCHEMBL16046663 0.77 LTA4H (0.62) LTA4HMAPTRAB9AMAOBGAA
SCHEMBL32665462 0.77 KDM4E (0.54) KDM1ARAB9ASMN1; SMN2L3MBTL1LMNA
SCHEMBL9047395 0.76 LTA4H (0.60) LTA4HRAB9ASMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A PRMT5 577/4885LTA4H 3778/4885KDM1A 4345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.